Literature DB >> 30668423

Phytochemical screening and preliminary clinical trials of the aqueous extract mixture of Andrographis paniculata (Burm. f.) Wall. ex Nees and Syzygium polyanthum (Wight.) Walp leaves in metformin treated patients with type 2 diabetes.

Elisabeth Catherina Widjajakusuma1, Arijanto Jonosewojo2, Lucia Hendriati3, Sumi Wijaya3, Adrianta Surjadhana3, Widayat Sastrowardoyo2, Nadia Monita4, Nafdsu Makhmudatul Muna4, Rachma Pantja Fajarwati4, Martha Ervina3, Senny Yesery Esar3, Lisa Soegianto3, Tirza Lang3, Cindy Heriyanti3.   

Abstract

BACKGROUND: Our previous preclinical study showed that the extract mixture (EM) of Andrographis paniculata (Burm. f.) Wall. ex Nees (AP) and Syzygium polyanthum (Wight.) Walp (SP) leaves had antidiabetic effects and were beneficial on alloxan-induced diabetic rats.
PURPOSE: The objectives of this study were to: 1) identify the phytochemical compounds present in aqueous extract of AP and SP and 2) examine the benefits of the EM of AP and SP leaves in lowering blood glucose in the presence of standard antidiabetic treatment using metformin in type 2 diabetic patients in Indonesian Traditional Medicine Polyclinic of Dr. Soetomo General Hospital in Surabaya.
METHODS: Phytochemical analysis of aqueous leaf extract of AP and SP was performed using standard chemical tests, TLC, and GC-MS. Furthermore, a total of 54 subjects with T2DM participated in this study and were randomly assigned to either the intervention group supplemented with the extract mixture of AP and SP at a dose 900  mg/day for 8 weeks, or the control group which received placebo tablets in a randomized placebo-controlled double-blinded parallel clinical trial. Both groups received metformin at dose 1000  mg/day. Body weight, blood pressure, fasting blood glucose, postprandial glucose, haemoglobin A1c, triglycerides, total cholesterol, low density lipoprotein, high density lipoprotein, and markers of liver and kidney damage were measured.
RESULTS: The results of phytochemical analysis showed that the glycosides, terpenoids, alkaloids, flavonoids, saponins, and tannins were found to be present in the extract mixture. GC-MS analyses of AP and SP showed the presence of 19 and 12 peaks, respectively. Methyl ester of 9-octadecenoic and eicosanoic acid were determined as the main constituents of both species. Moreover, the results of clinical study suggested that the extract mixture improved the decrease of fasting blood glucose and postprandial glucose, significantly lowered body mass index compared with the control group. The EM appeared beneficial for SGPT values and uric acid levels.
CONCLUSION: Overall, the results of this study suggested the potential beneficial effects of the extract mixture for use as complementary medicine alongside conventional treatment of metformin. The extract mixture contained many highly potent compounds for treating T2DM and preventing short- and long-term risk complications of diabetes.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Andrographis paniculata; Clinical study; GC–MS; Metformin; Syzygium polyanthum; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2018        PMID: 30668423     DOI: 10.1016/j.phymed.2018.07.002

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  9 in total

1.  Hypoglycemic Effect of a Combined Andrographis paniculata and Caesalpinia sappan Extract in Streptozocin-Induced Diabetic Rats.

Authors:  Febrika Wediasari; Gumilar A Nugroho; Zahra Fadhilah; Berna Elya; Heri Setiawan; Tjandrawati Mozef
Journal:  Adv Pharmacol Pharm Sci       Date:  2020-11-10

Review 2.  Traditional uses, pharmacological activities, and phytochemical constituents of the genus Syzygium: A review.

Authors:  A B M Neshar Uddin; Farhad Hossain; A S M Ali Reza; Mst Samima Nasrin; A H M Khurshid Alam
Journal:  Food Sci Nutr       Date:  2022-03-04       Impact factor: 3.553

3.  Multi-Functional Carbon Dots from an Ayurvedic Medicinal Plant for Cancer Cell Bioimaging Applications.

Authors:  Gaurav Gopal Naik; Md Bayazeed Alam; Vivek Pandey; Debadatta Mohapatra; Pawan K Dubey; Avanish S Parmar; Alakh N Sahu
Journal:  J Fluoresc       Date:  2020-02-22       Impact factor: 2.217

Review 4.  Phytopharmacological Possibilities of Bird Cherry Prunus padus L. and Prunus serotina L. Species and Their Bioactive Phytochemicals.

Authors:  Aleksandra Telichowska; Joanna Kobus-Cisowska; Piotr Szulc
Journal:  Nutrients       Date:  2020-07-02       Impact factor: 5.717

Review 5.  Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery.

Authors:  Jinjoo Lee; Seungjin Noh; Suhyun Lim; Bonglee Kim
Journal:  Antioxidants (Basel)       Date:  2021-01-09

Review 6.  Andrographis paniculata (Burm. f.) Wall. ex Nees: An Updated Review of Phytochemistry, Antimicrobial Pharmacology, and Clinical Safety and Efficacy.

Authors:  Sanower Hossain; Zannat Urbi; Hidayah Karuniawati; Ramisa Binti Mohiuddin; Ahmed Moh Qrimida; Akrm Mohamed Masaud Allzrag; Long Chiau Ming; Ester Pagano; Raffaele Capasso
Journal:  Life (Basel)       Date:  2021-04-16

Review 7.  A review on the molecular basis underlying the protective effects of Andrographis paniculata and andrographolide against myocardial injury.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Soelaiman Ima-Nirwana
Journal:  Drug Des Devel Ther       Date:  2021-11-10       Impact factor: 4.162

8.  Ameliorative potential of Operculina turpethum against streptozotocin-induced diabetes in rats: biochemical and histopathological studies.

Authors:  Neeraj Choudhary; Gopal L Khatik; Rekha Sharma; Navneet Khurana; Richard Lobo; Shvetank Bhatt; Devesh Tewari; Ashish Suttee
Journal:  3 Biotech       Date:  2021-06-02       Impact factor: 2.893

Review 9.  An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review.

Authors:  Junnan Shi; Hao Hu; Joanna Harnett; Xiaoting Zheng; Zuanji Liang; Yi-Tao Wang; Carolina Oi Lam Ung
Journal:  Chin Med       Date:  2019-11-29       Impact factor: 5.455

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.